12:00 AM
Jan 08, 2007
 |  BioCentury  |  Finance

Late stage milestones

Late stage milestones

Company name Product name Indication Event Milestone
Abeille AB-1001 Emesis Submit NDA 3Q07
Acambis (LSE:ACM; ACAM) ChimeriVax-JE vaccine Japanese encephalitis Final Ph III data 1Q07
ActivBiotics Rifalazil Peripheral vascular disease (PVD) Ph III data 2H07
Acusphere (ACUS)/Nycomed AI-700 Ultrasound contrast agent Ph III (RAMP-2) data; Submit NDA 2Q07; 2H07
Adolor (ADLR)/GlaxoSmithKline (LSE:GSK; GSK) Entereg alvimopan Post-operative ileus (POI) Ph III data 2Q07
Advanced Life Sciences (ADLS) Cethromycin Pneumonia Ph III data; submit NDA 1Q07
Advanced Magnetics (AMAG) Ferumoxytol Anemia Submit NDA 2H07
Allos (ALTH) Efaproxyn efaproxiral Brain metastases Ph III data Mid-2007
AP Pharma (APPA) APF530 Emesis Ph III data 2H07
Arena (ARNA) Lorcaserin Weight gain Interim Ph III data 1H07
Arpida (SWX:ARPN) Iclaprim injection Skin and skin structure infection (SSSI) Submit NDA 2007
AtheroGenics (AGIX)/AstraZeneca (LSE:AZN; AZN) AGI-1067 Atherosclerosis Ph III data Early 07
Basilea (SWX:BSLN)

Read the full 1092 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >